D. Elkharrat, L. Arrouy, F. Benhamou, A. Dray, J. Grenet et al., ??pid??miologie de l???infection urinaire communautaire de l???adulte en France, p.1, 2007.
DOI : 10.1007/978-2-287-48617-3_1

Y. Michel-briand, Une histoire de la résistance aux antibiotiques. A propos de six bactéries, 2009.

D. L. Paterson and R. A. Bonomo, Extended-Spectrum Beta-Lactamases, Seminars in Respiratory and Critical Care Medicine, vol.24, issue.1, pp.657-686, 2005.
DOI : 10.1055/s-2003-37919

J. D. Pitout, P. Nordmann, K. B. Laupland, and L. Poirel, Emergence of Enterobacteriaceae producing extended-spectrum ??-lactamases (ESBLs) in the community, Journal of Antimicrobial Chemotherapy, vol.56, issue.1, pp.52-59, 2005.
DOI : 10.1093/jac/dki166

R. P. Ambler, The Structure of <latex>$\beta$</latex>-Lactamases, Philosophical Transactions of the Royal Society B: Biological Sciences, vol.289, issue.1036, pp.321-331, 1980.
DOI : 10.1098/rstb.1980.0049

H. Knothe, P. Shah, V. Krcmery, M. Antal, and S. Mitsuhashi, Ubertragbare Resistenz gegen??ber Cefotaxim, Cefoxitin, Cefamandol und Cefuroxim in klinischen Isolaten von Klebsiella pneumoniae und Serratia marcescens, Infection, vol.147, issue.6, pp.315-317, 1983.
DOI : 10.1007/BF01641355

D. Sirot, J. Sirot, R. Labia, A. Morand, P. Courvalin et al., : identification of CTX-1, a novel ??-lactamase, Journal of Antimicrobial Chemotherapy, vol.20, issue.3, pp.323-334, 1987.
DOI : 10.1093/jac/20.3.323

A. Philippon, R. Labia, and G. Jacoby, Extended-spectrum beta-lactamases., Antimicrobial Agents and Chemotherapy, vol.33, issue.8, pp.1131-1136, 1989.
DOI : 10.1128/AAC.33.8.1131

R. Bonnet, Growing Group of Extended-Spectrum ??-Lactamases: the CTX-M Enzymes, Antimicrobial Agents and Chemotherapy, vol.48, issue.1, pp.1-14, 2004.
DOI : 10.1128/AAC.48.1.1-14.2004

J. D. Pitout and K. B. Laupland, Extended-spectrum ??-lactamase-producing Enterobacteriaceae: an emerging public-health concern, The Lancet Infectious Diseases, vol.8, issue.3, pp.159-166, 2008.
DOI : 10.1016/S1473-3099(08)70041-0

P. Woerther, C. Angebault, M. Lescat, E. Ruppé, D. Skurnik et al., in the Community: Lessons from the Study of a Remote and Controlled Population, The Journal of Infectious Diseases, vol.202, issue.4, pp.515-523, 2010.
DOI : 10.1086/654883

F. W. Goldstein, Antibiotic Susceptibility of Bacterial Strains Isolated from Patients with Community-Acquired Urinary Tract Infections in France, European Journal of Clinical Microbiology & Infectious Diseases, vol.19, issue.2, pp.112-117, 2000.
DOI : 10.1007/s100960050440

H. Sénéchal, M. Eveillard, and N. Garreau, Surveillance des bactéries multirésistantes. Résultats année, CCLIN OUEST, 2011.

C. Arpin, C. Quentin, F. Grobost, E. Cambau, J. Robert et al., Nationwide survey of extended-spectrum ??-lactamase-producing Enterobacteriaceae in the French community setting, Journal of Antimicrobial Chemotherapy, vol.63, issue.6, pp.1205-1214, 2009.
DOI : 10.1093/jac/dkp108

URL : https://hal.archives-ouvertes.fr/hal-00426312

S. Thibaut, J. Caillon, G. Grandjean, and F. Ballereau, Réseau MedQual: surveillance de l'évolution des résistances des souches d'Escherichia coli isolées en ville, 2012.

A. Carattoli, Animal reservoirs for extended spectrum beta-lactamase producers, Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis, vol.14, pp.117-123, 2008.

E. M. Wellington, A. B. Boxall, P. Cross, E. J. Feil, W. H. Gaze et al., The role of the natural environment in the emergence of antibiotic resistance in Gram-negative bacteria, The Lancet Infectious Diseases, vol.13, issue.2, pp.155-165, 2013.
DOI : 10.1016/S1473-3099(12)70317-1

R. Ben-ami, J. Rodríguez-baño, H. Arslan, J. D. Pitout, C. Quentin et al., A Multinational Survey of Risk Factors for Infection with Extended???Spectrum ?????Lactamase???Producing Enterobacteriaceae in Nonhospitalized Patients, Clinical Infectious Diseases, vol.49, issue.5, pp.682-690, 2009.
DOI : 10.1086/604713

URL : https://hal.archives-ouvertes.fr/hal-00426315

E. Calbo, V. Romaní, M. Xercavins, L. Gómez, C. G. Vidal et al., Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum ??-lactamases, Journal of Antimicrobial Chemotherapy, vol.57, issue.4, pp.780-783, 2006.
DOI : 10.1093/jac/dkl035

R. Colodner, W. Rock, B. Chazan, N. Keller, N. Guy et al., Risk Factors for the Development of Extended-Spectrum Beta-Lactamase-Producing Bacteria in Nonhospitalized Patients, European Journal of Clinical Microbiology & Infectious Diseases, vol.23, issue.3, pp.163-167, 2004.
DOI : 10.1007/s10096-003-1084-2

C. Hsieh, Y. Shen, and K. Hwang, Clinical Implications, Risk Factors and Mortality Following Community-onset Bacteremia Caused by Extended-spectrum ??-lactamase (ESBL) and non-ESBL Producing Escherichia coli, Journal of Microbiology, Immunology and Infection, vol.43, issue.3, pp.240-248, 2010.
DOI : 10.1016/S1684-1182(10)60038-2

C. Kang, Y. M. Wi, M. Y. Lee, K. S. Ko, D. R. Chung et al., Epidemiology and Risk Factors of Community Onset Infections Caused by Extended-Spectrum ??-Lactamase-Producing Escherichia coli Strains, Journal of Clinical Microbiology, vol.50, issue.2, pp.312-317, 2012.
DOI : 10.1128/JCM.06002-11

C. Kang, J. Song, D. R. Chung, K. R. Peck, K. S. Ko et al., Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli, C. Moon, S. Y. Shin, and Korean Network for Study of Infectious Diseases (KONSID) Int. J. Antimicrob. Agents, vol.36, issue.3, pp.284-287, 2010.

R. Leistner, E. Meyer, P. Gastmeier, Y. Pfeifer, C. Eller et al., Risk Factors Associated with the Community-Acquired Colonization of Extended-Spectrum Beta-Lactamase (ESBL) Positive Escherichia Coli. An Exploratory Case-Control Study, PLoS ONE, vol.2, issue.9, p.74323, 2013.
DOI : 10.1371/journal.pone.0074323.t004

L. Siedelman, S. Kline, and S. Duval, Risk factors for community- and health facility???acquired extended-spectrum ??-lactamase???producing bacterial infections in patients at the University of Minnesota Medical Center, Fairview, American Journal of Infection Control, vol.40, issue.9, pp.849-853, 2012.
DOI : 10.1016/j.ajic.2011.10.019

C. Neulier, G. Birgand, E. Ruppé, L. Armand-lefèvre, I. Lolom et al., Enterobacteriaceae bacteremia: Risk factors for ESBLPE, M??decine et Maladies Infectieuses, vol.44, issue.1, 2013.
DOI : 10.1016/j.medmal.2013.11.003

M. Nicolas-chanoine, V. Jarlier, J. Robert, G. Arlet, L. Drieux et al., Patient's Origin and Lifestyle Associated with CTX-M-Producing Escherichia coli: A Case-Control-Control Study, PLoS ONE, vol.14, issue.1, p.30498, 2012.
DOI : 10.1371/journal.pone.0030498.t006

. Ministère-du-travail, . Emploi, . De, and . Santé, Plan national d'alerte sur les antibiotiques 2011- 2016, 2011.

H. Conseil-de-la-santé-publique, Recommandations relatives aux mesures à mettre en oeuvre pour prévenir l'émergence des entérobactéries BLSE et lutter contre leur dissémination, 2010.

I. C. Gyssens and B. J. Kullberg, Improving the quality of antimicrobial drug use can result in cost containment, Pharmacy World & Science, vol.15, issue.6, pp.163-167, 1995.
DOI : 10.1007/BF01879711

. Comité, Antibiogramme -Société Française de Microbiologie Recommandations 2013, 2013.

D. Fournier, C. Chirouze, J. Leroy, P. Cholley, D. Talon et al., Alternatives to carbapenems in ESBL-producing Escherichia coli infections, M??decine et Maladies Infectieuses, vol.43, issue.2, pp.62-66, 2013.
DOI : 10.1016/j.medmal.2013.01.006

URL : https://hal.archives-ouvertes.fr/hal-00802661

S. Auer, A. Wojna, and M. Hell, Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli

C. Rodríguez-avial, I. Rodríguez-avial, E. Hernández, and J. J. Picazo, [Increasing prevalence of fosfomycin resistance in extended-spectrum-beta-lactamase-producing Escherichia coli urinary isolates, Rev. Esp. Quimioter. Publ. Of. Soc. Esp. Quimioter, vol.26, issue.1, pp.43-46, 2005.

C. Sizun, Etude rétrospective sur la prise en charge des infections urinaires à entérobactéries productrices de bêta-lactamases à spectre étendu par les médecins généralistes libéraux, 2014.

S. Française-de-microbiologie, Argumentaires pour les recommandations faites en 2011 à propos des céphalosporines de 3e génération et l'aztréonam vis-à-vis des entérobactéries, 2011.

C. Miclot, Etude des pratiques des médecins généralistes dans la prise en charge des infections uriniares à entérobactéries sécrétrices de bêta-lactamase à spectre étendu, 2013.
DOI : 10.1016/s0399-077x(14)70249-5

K. B. Laupland, D. L. Church, J. Vidakovich, M. Mucenski, and J. D. Pitout, Community-onset extended-spectrum ??-lactamase (ESBL) producing Escherichia coli: Importance of international travel, Journal of Infection, vol.57, issue.6, pp.441-448, 2008.
DOI : 10.1016/j.jinf.2008.09.034

R. Friedmann, D. Raveh, E. Zartzer, B. Rudensky, E. Broide et al., Conclusions., Infection Control & Hospital Epidemiology, vol.8, issue.06, pp.534-542, 2009.
DOI : 10.1016/j.jhin.2008.02.003

R. Ben-ami, M. J. Schwaber, S. Navon-venezia, D. Schwartz, M. Giladi et al., Influx of Extended-Spectrum ??-Lactamase--Producing Enterobacteriaceae into the Hospital, Clinical Infectious Diseases, vol.42, issue.7, pp.925-934, 2006.
DOI : 10.1086/500936

G. Birgand, L. Armand-lefevre, I. Lolom, E. Ruppe, A. Andremont et al., Duration of colonization by extended-spectrum ??-lactamase-producing Enterobacteriaceae after hospital discharge, American Journal of Infection Control, vol.41, issue.5, pp.443-447, 2013.
DOI : 10.1016/j.ajic.2012.05.015

J. R. Zahar, F. Lanternier, F. Mechai, F. Filley, F. Taieb et al., Duration of colonisation by Enterobacteriaceae producing extended-spectrum ??-lactamase and risk factors for persistent faecal carriage, Journal of Hospital Infection, vol.75, issue.1, pp.76-78, 2010.
DOI : 10.1016/j.jhin.2009.11.010

R. Alsterlund, C. Axelsson, and B. Olsson-liljequist, Long-term carriage of extended-spectrum betalactamase-producing Escherichia coli, " Scand, J. Infect. Dis, vol.44, issue.1, pp.51-54, 2012.

A. Unité-de-la-transparence, Avis de la Commission -Invanz 1g, poudre pour solution à diluer pour perfusion, 2003.

. Comité-de-l-'antibiogramme-de-la-société-française-de-microbiologie, Recommandations 2014).pdf.. [53] Evolution des consommations d'antibiotiques en France entre : nouveau rapport d'analyse de l'ANSM -Point d'Information -ANSM : Agence nationale de sécurité du médicament et des produits de santé Available: http://ansm.sante.fr/S-informer/Points-d-information- Points-d-information/Evolution-des-consommations-d-antibiotiques-en-France, 2000.

A. Zucconi, Le Kit BLSE: un outil d'aide à la prise en charge des infections urinaires communautaires à Escherichia coli porteur d'une beta-lactamase à spectre élargi: évaluation de la procédure de diffusion, 2013.